Responses of medical students to case-based questions on four cases of patient blood management
| Case | Question | Response | No. of responses (%) (total=12) |
|---|---|---|---|
| 1 | Is immediate red blood cell transfusion required? | Not required | 11* (91.7) |
| What could be considered as an alternative transfusion treatment? | IDA evaluation | 12 (100.0) | |
| What kind of transfusion adverse event occurred? | AHTR | 4 (33.3) | |
| TRALI | 10 (83.3) | ||
| Anaphylaxis | 8 (66.7) | ||
| Which specially modified blood products should be chosen during transfusion? | Washing for an anaphylactoid reaction | 8 (66.7) | |
| 2 | Is immediate red blood cell transfusion required? | Not required | 11 (91.7) |
| What could be considered as an alternative transfusion treatment? | MDS evaluation (prognostic category, serum EPO, and RPI) | 1 (8.3) | |
| ESA | 1 (8.3) | ||
| MA evaluation | 8† (66.7) | ||
| Vitamin B12, folate supplementation | 9 (75.0) | ||
| What kind of transfusion adverse event occurred? | DHTR | 11 (91.7) | |
| Which specially modified blood products should be chosen during transfusion? | Leukoreduction for MDS | 2 (16.7) | |
| Irradiation for MDS | 2 (16.7) | ||
| Antigen-negative blood for DHTR | 10 (83.3) | ||
| 3 | Is immediate red blood cell transfusion required? | Not required | 12 (100.0) |
| What could be considered as an alternative transfusion treatment? | IDA evaluation | 12 (100.0) | |
| Iron supply | 12 (100.0) | ||
| What kind of transfusion adverse event occurred? | FNHTR | 11 (91.7) | |
| Which specially modified blood products should be chosen during transfusion? | Leukoreduction for FNHTR | 11 (91.7) |